Octave Specialty Group IncOSG
Price$4.30

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
Analyst Coverage
2analysts covering
As of 18 Aug 2026
FY EPS (est.)
$0.45next fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Total P&C Premium Production Quarterly531M
Insurance Distribution Organic Revenue Growth Quarterly42.0%
Everspan Active Programs Loss Ratio Quarterly57.0%
Insurance Distribution Segment Revenue Quarterly79M
Watch Items
  • Everspan Litigation and Run-off Claims DevelopmentTrigger: Any further adverse development or legal expenses from run-off programs exceeding $2 million in a quarter.Action: Re-evaluate underwriting risk controls and reserve adequacy for legacy run-off programs.
  • ArmadaCare Integration and Supplemental Health GrowthTrigger: ArmadaCare organic revenue growth falling below 10% year-over-year.Action: Review cross-selling strategies and distribution channel performance across the broader MGA platform.
Sign in / Sign up to read more

Research as of 20 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.